ARCHIVES

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

House Aims to End Budget Markup Early; Natcher Sees Most Difficult Year

June 26, 1992

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007

FDA Policy On Support Of Medical Education Near Final Form

February 5, 1993

In Brief: Orvile Kelley, Make Today Count Founder, Dies; Elli Kohen Honored By Pap Institute

July 4, 1980

Proposed Criteria For Establishing Carcinogenicity Listed

November 21, 1975

NCI, NIH Make Half-Hearted Pitch For Cancer Act Before Seemingly Uninterested Rogers Committee

March 10, 1978